Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Israeli Researchers to Explore Treating Asthma With Medical Cannabis
Error: Contact form not found.
by JNS.org
Medical cannabis at Israel’s third annual CannaTech conference in March 2017. Photo: Adam Abrams.
JNS.org – The Israeli-British cannabis biotech start-up CIITECH announced on Tuesday that it will fund a research project in collaboration with the Hebrew University of Jerusalem exploring methods for treating asthma with medical cannabis.
The research project will be conducted at Hebrew University’s Multidisciplinary Center on Cannabinoid Research, and led by researchers Profs. Raphael Mechoulam and Francesca Levi-Schaffer.
Mechoulam, a pioneer in the medical cannabis field, discovered THC — the primary psychoactive compound in the plant — in the 1970s. Levi-Schaffer is an expert in asthma research.
The study focuses on researching the effects of the non-psychoactive cannabis compound CBD and identifying its potential inhibitory effect on allergic airway inflammation that causes asthma attacks.
“We know that CBD has anti-inflammatory properties and we’re looking forward to investigating whether this will be effective on treating asthma and related respiratory conditions,” said Mechoulam.
“Most of the symptoms of allergic disease patients are controlled by either symptomatic drugs or corticosteroids,” stated Levi-Schaffer. “However, some patients are steroid-resistant and allergic diseases such as severe asthma have been labeled as unmet clinical needs by the WHO (World Health Organization). We believe our research will provide a novel and effective solution to treating this condition.”
In recent years, Israel has become a hub for the study and distribution of medical cannabis. In August, the Israeli government approved a new measure allowing for international exports of the plant.
